Cardiac Positron Emission Tomography

Frank M. Bengel, Takahiro Higuchi, Mehrbod S. Javadi, Riikka Lautamäki

Research output: Contribution to journalReview article

185 Citations (Scopus)

Abstract

Positron emission tomography (PET) is a powerful, quantitative imaging modality that has been used for decades to noninvasively investigate cardiovascular biology and physiology. Due to limited availability, methodologic complexity, and high costs, it has long been seen as a research tool and as a reference method for validation of other diagnostic approaches. This perception, fortunately, has changed significantly within recent years. Increasing diversity of therapeutic options for coronary artery disease, and increasing specificity of novel therapies for certain biologic pathways, has resulted in a clinical need for more accurate and specific diagnostic techniques. At the same time, the number of PET centers continues to grow, stimulated by PET's success in oncology. Methodologic advances as well as improved radiotracer availability have further contributed to more widespread use. Evidence for diagnostic and prognostic usefulness of myocardial perfusion and viability assessment by PET is increasing. Some studies suggest overall cost-effectiveness of the technique despite higher costs of a single study, because unnecessary follow-up procedures can be avoided. The advent of hybrid PET-computed tomography (CT), which enables integration of PET-derived biologic information with multislice CT-derived morphologic information, and the key role of PET in the development and translation of novel molecular-targeted imaging compounds, have further contributed to more widespread acceptance. Today, PET promises to play a leading diagnostic role on the pathway toward a future of high-powered, comprehensive, personalized, cardiovascular medicine. This review summarizes the state-of-the-art in current imaging methodology and clinical application, and outlines novel developments and future directions.

Original languageEnglish
Pages (from-to)1-15
Number of pages15
JournalJournal of the American College of Cardiology
Volume54
Issue number1
DOIs
Publication statusPublished - Jun 30 2009
Externally publishedYes

Fingerprint

Positron-Emission Tomography
Cardiovascular Physiological Phenomena
Costs and Cost Analysis
Precision Medicine
Biological Therapy
Molecular Imaging
Multidetector Computed Tomography
Cost-Benefit Analysis
Coronary Artery Disease
Perfusion
Research

Keywords

  • hybrid imaging
  • molecular imaging
  • myocardial perfusion
  • myocardial viability
  • positron emission tomography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac Positron Emission Tomography. / Bengel, Frank M.; Higuchi, Takahiro; Javadi, Mehrbod S.; Lautamäki, Riikka.

In: Journal of the American College of Cardiology, Vol. 54, No. 1, 30.06.2009, p. 1-15.

Research output: Contribution to journalReview article

Bengel, Frank M. ; Higuchi, Takahiro ; Javadi, Mehrbod S. ; Lautamäki, Riikka. / Cardiac Positron Emission Tomography. In: Journal of the American College of Cardiology. 2009 ; Vol. 54, No. 1. pp. 1-15.
@article{f421fccedf904495b5be41e7eb861f65,
title = "Cardiac Positron Emission Tomography",
abstract = "Positron emission tomography (PET) is a powerful, quantitative imaging modality that has been used for decades to noninvasively investigate cardiovascular biology and physiology. Due to limited availability, methodologic complexity, and high costs, it has long been seen as a research tool and as a reference method for validation of other diagnostic approaches. This perception, fortunately, has changed significantly within recent years. Increasing diversity of therapeutic options for coronary artery disease, and increasing specificity of novel therapies for certain biologic pathways, has resulted in a clinical need for more accurate and specific diagnostic techniques. At the same time, the number of PET centers continues to grow, stimulated by PET's success in oncology. Methodologic advances as well as improved radiotracer availability have further contributed to more widespread use. Evidence for diagnostic and prognostic usefulness of myocardial perfusion and viability assessment by PET is increasing. Some studies suggest overall cost-effectiveness of the technique despite higher costs of a single study, because unnecessary follow-up procedures can be avoided. The advent of hybrid PET-computed tomography (CT), which enables integration of PET-derived biologic information with multislice CT-derived morphologic information, and the key role of PET in the development and translation of novel molecular-targeted imaging compounds, have further contributed to more widespread acceptance. Today, PET promises to play a leading diagnostic role on the pathway toward a future of high-powered, comprehensive, personalized, cardiovascular medicine. This review summarizes the state-of-the-art in current imaging methodology and clinical application, and outlines novel developments and future directions.",
keywords = "hybrid imaging, molecular imaging, myocardial perfusion, myocardial viability, positron emission tomography",
author = "Bengel, {Frank M.} and Takahiro Higuchi and Javadi, {Mehrbod S.} and Riikka Lautam{\"a}ki",
year = "2009",
month = "6",
day = "30",
doi = "10.1016/j.jacc.2009.02.065",
language = "English",
volume = "54",
pages = "1--15",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Cardiac Positron Emission Tomography

AU - Bengel, Frank M.

AU - Higuchi, Takahiro

AU - Javadi, Mehrbod S.

AU - Lautamäki, Riikka

PY - 2009/6/30

Y1 - 2009/6/30

N2 - Positron emission tomography (PET) is a powerful, quantitative imaging modality that has been used for decades to noninvasively investigate cardiovascular biology and physiology. Due to limited availability, methodologic complexity, and high costs, it has long been seen as a research tool and as a reference method for validation of other diagnostic approaches. This perception, fortunately, has changed significantly within recent years. Increasing diversity of therapeutic options for coronary artery disease, and increasing specificity of novel therapies for certain biologic pathways, has resulted in a clinical need for more accurate and specific diagnostic techniques. At the same time, the number of PET centers continues to grow, stimulated by PET's success in oncology. Methodologic advances as well as improved radiotracer availability have further contributed to more widespread use. Evidence for diagnostic and prognostic usefulness of myocardial perfusion and viability assessment by PET is increasing. Some studies suggest overall cost-effectiveness of the technique despite higher costs of a single study, because unnecessary follow-up procedures can be avoided. The advent of hybrid PET-computed tomography (CT), which enables integration of PET-derived biologic information with multislice CT-derived morphologic information, and the key role of PET in the development and translation of novel molecular-targeted imaging compounds, have further contributed to more widespread acceptance. Today, PET promises to play a leading diagnostic role on the pathway toward a future of high-powered, comprehensive, personalized, cardiovascular medicine. This review summarizes the state-of-the-art in current imaging methodology and clinical application, and outlines novel developments and future directions.

AB - Positron emission tomography (PET) is a powerful, quantitative imaging modality that has been used for decades to noninvasively investigate cardiovascular biology and physiology. Due to limited availability, methodologic complexity, and high costs, it has long been seen as a research tool and as a reference method for validation of other diagnostic approaches. This perception, fortunately, has changed significantly within recent years. Increasing diversity of therapeutic options for coronary artery disease, and increasing specificity of novel therapies for certain biologic pathways, has resulted in a clinical need for more accurate and specific diagnostic techniques. At the same time, the number of PET centers continues to grow, stimulated by PET's success in oncology. Methodologic advances as well as improved radiotracer availability have further contributed to more widespread use. Evidence for diagnostic and prognostic usefulness of myocardial perfusion and viability assessment by PET is increasing. Some studies suggest overall cost-effectiveness of the technique despite higher costs of a single study, because unnecessary follow-up procedures can be avoided. The advent of hybrid PET-computed tomography (CT), which enables integration of PET-derived biologic information with multislice CT-derived morphologic information, and the key role of PET in the development and translation of novel molecular-targeted imaging compounds, have further contributed to more widespread acceptance. Today, PET promises to play a leading diagnostic role on the pathway toward a future of high-powered, comprehensive, personalized, cardiovascular medicine. This review summarizes the state-of-the-art in current imaging methodology and clinical application, and outlines novel developments and future directions.

KW - hybrid imaging

KW - molecular imaging

KW - myocardial perfusion

KW - myocardial viability

KW - positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=67449084319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449084319&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2009.02.065

DO - 10.1016/j.jacc.2009.02.065

M3 - Review article

C2 - 19555834

AN - SCOPUS:67449084319

VL - 54

SP - 1

EP - 15

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 1

ER -